GuoRui Ruan

8PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMedical infection agents (incl. prions)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 26, 2025
Prognostic value of CEBPA bZIP signatures in cytogenetically normal acute myeloid leukaemia.

Li-Xin Wu, Ming-Yue Liao, Ming-Yue Zhao

|Nov 22, 2023
Mutations in DEAD/H-box helicase 11 correlate with increased relapse risk in adults with acute myeloid leukaemia with normal cytogenetics.

Ya-Lan Zhou, Ming-Yue Zhao, Robert Peter Gale

|Aug 25, 2023
Prognostic impact of FLT3-ITD mutation on NPM1+ acute myeloid leukaemia patients and related molecular mechanisms.

Xin'an Pan, Yingjun Chang, Guorui Ruan

|Mar 18, 2022
Prognostic implications of the detection of measurable residual disease and mutations based on next-generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA.

Jing Wang, Hao Jiang, Yu Jing

|Apr 14, 2020
Osteoclast stimulatory transmembrane protein (OC-STAMP) is a promising molecular prognostic indicator for multiple myeloma.

Zi-Long Wang, Yang Liu, Ya-Lan Zhou

|Feb 28, 2020
Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD).

Ya-Lan Zhou, Li-Xin Wu, Robert Peter Gale

Pageof 2

Frequent Collaborators

6 joint publications

Qian Jiang

5 joint publications

LanPing Xu

4 joint publications

KaiYan Liu

3 joint publications

Xiao-Jun Huang